Press Releases
Novartis’ midostaurin achieves 60% response rate in advanced systemic mastocytosis
Novartis announced that The New England Journal of Medicine published data for PKC412 demonstrating an overall response rate, defined as a major or partial...
News
GSK start of phase- I oncology study with its ICOS agonist antibody
GSK announced the start of a phase I clinical trial with GSK3359609, an investigational inducibile T-cell costimulator (ICOS) agonist antibody. ICOS is a co-stimulatory...
Press Releases
Merck, Premier Inc collaborate to improve care for osteoporosis patients
Merck and Premier Inc , a leading healthcare improvement company, have agreed to collaborate on the co-development of solutions to help improve population health....
Press Releases
FDA accepted Teva’s Fluticasone Propionate and Fluticasone Propionate RespiClick Inhalers
Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA has accepted for review the company’s new drug applications (NDAs) for two products for adolescent...
Press Releases
EU approves Astrazeneca Plc’s New Antibiotic Zavicefta
AstraZeneca announced that the EC has granted marketing authorisation for Zavicefta , a new combination antibiotic for the treatment of patients with serious Gram-negative...
Press Releases
Pfizer says Two additional late stage studies of cholesterol drug met goals
Pfizer Inc. announced two additional Phase 3 bococizumab trials, SPIRE-HR and SPIRE-FH , met their primary endpoint, demonstrating a significant reduction in the percent...
Press Releases
Novo Nordisk receives the EMA marketing approval of the mylife YpsoPump insulin pump
Novo Nordisk announces the EMA marketing approval of the mylife(TM) YpsoPump® insulin pump for use with prefilled pump cartridge NovoRapid®PumpCart®. The approval is a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read